(Q40030363)

16 September 2017

title

Intravitreal administration of the anti-TNF monoclonal antibody infliximab in the rabbit (English)

1 reference

16 September 2017

0 references

3

Petros P Sfikakis

1 reference

16 September 2017

author name string

Panagiotis G Theodossiadis

1

1 reference

16 September 2017

Vasilios S Liarakos

2

1 reference

16 September 2017

Alexander Charonis

4

1 reference

16 September 2017

Georgios Agrogiannis

5

1 reference

16 September 2017

Nikolaos Kavantzas

6

1 reference

16 September 2017

Ioannis A Vergados

7

1 reference

16 September 2017

publication date

4 November 2008

1 reference

Graefe's Archive for Clinical and Experimental Ophthalmology

16 September 2017

published in

1 reference

16 September 2017

volume

247

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

273-281

1 reference

https://scigraph.springernature.com/pub.10.1007/s00417-008-0967-4

16 September 2017

exact match

0 references

cites work

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00417-008-0967-4

Lipid hydroperoxide-induced tumor necrosis factor (TNF)- , vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition

21 January 2018

1 reference

12 December 2020

Regression of neovascular age-related macular degeneration following infliximab therapy

1 reference

12 December 2020

Human RPE expression of cell survival factors

1 reference

12 December 2020

Treatment of acute uveitis associated with Crohn's disease and sacroileitis with infliximab

1 reference

12 December 2020

Adverse skin reactions to infliximab in the treatment of intraocular inflammation

1 reference

12 December 2020

Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab

1 reference

12 December 2020

Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.

1 reference

12 December 2020

The second harmonic of the electroretinogram to sinusoidal flicker: spatiotemporal properties and clinical application

1 reference

12 December 2020

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

12 December 2020

Standard for clinical electroretinography (2004 update).

1 reference

12 December 2020

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

1 reference

12 December 2020

Favorable response to high-dose infliximab for refractory childhood uveitis

1 reference

12 December 2020

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

12 December 2020

[TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy]

1 reference

12 December 2020

Intravitreal toxicity of high-dose etanercept

1 reference

12 December 2020

A pilot study on ocular safety of intravitreal infliximab in a rabbit model.

1 reference

12 December 2020

Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells.

1 reference

12 December 2020

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

1 reference

12 December 2020

Pharmacokinetics and safety of intravitreally delivered etanercept

1 reference

12 December 2020

Risks of intravitreous injection: a comprehensive review

1 reference

12 December 2020

The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes

1 reference

12 December 2020

Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin).

1 reference

12 December 2020

The pathogenesis and treatment of optic disc swelling in neurosarcoidosis: a unique therapeutic response to infliximab

1 reference

12 December 2020

Infliximab in chronic ocular inflammation

1 reference

12 December 2020

Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction

1 reference

12 December 2020

Treating intraocular inflammatory disease in the 21st century

1 reference

12 December 2020

Infliximab for chronic cystoid macular edema associated with uveitis

1 reference

12 December 2020

Anti-TNF-α therapy for uveitis: Behçet and beyond

1 reference

12 December 2020

Safety of biologic therapies--an update

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

1 reference

12 December 2020

Intravitreal infliximab and choroidal neovascularization in an animal model

1 reference

12 December 2020

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

1 reference

12 December 2020

Cone dark adaptation: the influence of halothane anesthesia

1 reference

12 December 2020

Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization.

1 reference

12 December 2020

Refractory Sarcoidosis Responding to Infliximab *

1 reference

12 December 2020

Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization

1 reference

12 December 2020

Ocular toxicity of intravitreous adalimumab (Humira) in the rabbit

1 reference

12 December 2020

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

1 reference

12 December 2020

10.1007/S00417-008-0967-4

Identifiers

DOI

1 reference

16 September 2017

1 reference